Mirae Asset Global Investments’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-430
| Closed | -$43.7K | – | 1628 |
|
|
2025
Q4 | $43.7K | Buy |
+430
| New | +$34.5K | ﹤0.01% | 1425 |
|
|
2025
Q2 | – | Sell |
-786
| Closed | -$34.3K | – | 1604 |
|
|
2025
Q1 | $34.3K | Buy |
+786
| New | +$39.8K | ﹤0.01% | 1309 |
|
|
2024
Q4 | – | Sell |
-750
| Closed | -$49.5K | – | 1617 |
|
|
2024
Q3 | $49.5K | Buy |
+750
| New | +$42.3K | ﹤0.01% | 1307 |
|
|
2024
Q2 | – | Sell |
-13,927
| Closed | -$940K | – | 1856 |
|
|
2024
Q1 | $940K | Sell |
13,927
-2,912
| -17% | -$184K | ﹤0.01% | 1573 |
|
|
2023
Q4 | $1.25M | Sell |
16,839
-258
| -2% | -$16.9K | ﹤0.01% | 1502 |
|
|
2023
Q3 | $1.17M | Buy |
17,097
+6,086
| +55% | +$516K | ﹤0.01% | 1450 |
|
|
2023
Q2 | $1.04M | Sell |
11,011
-1,756
| -14% | -$137K | ﹤0.01% | 1542 |
|
|
2023
Q1 | $866K | Sell |
12,767
-37,519
| -75% | -$2.41M | ﹤0.01% | 1619 |
|
|
2022
Q4 | $2.5M | Sell |
50,286
-11,914
| -19% | -$487K | 0.01% | 1043 |
|
|
2022
Q3 | $2.03M | Sell |
62,200
-37,456
| -38% | -$1.54M | 0.01% | 1128 |
|
|
2022
Q2 | $3.92M | Sell |
99,656
-13,084
| -12% | -$700K | 0.01% | 914 |
|
|
2022
Q1 | $7.88M | Buy |
112,740
+18,357
| +19% | +$1.34M | 0.02% | 735 |
|
|
2021
Q4 | $7.35M | Sell |
94,383
-7,812
| -8% | -$689K | 0.02% | 775 |
|
|
2021
Q3 | $9.76M | Buy |
102,195
+26,000
| +34% | +$2.75M | 0.02% | 656 |
|
|
2021
Q2 | $9.47M | Buy |
76,195
+11,766
| +18% | +$1.4M | 0.03% | 652 |
|
|
2021
Q1 | $8.49M | Sell |
64,429
-25,440
| -28% | -$3.48M | 0.03% | 585 |
|
|
2020
Q4 | $11.9M | Buy |
89,869
+41,752
| +87% | +$5.05M | 0.04% | 443 |
|
|
2020
Q3 | $4.91M | Buy |
48,117
+10,199
| +27% | +$881K | 0.02% | 555 |
|
|
2020
Q2 | $3.3M | Buy |
37,918
+2,499
| +7% | +$200K | 0.02% | 584 |
|
|
2020
Q1 | $2.05M | Buy |
35,419
+17,470
| +97% | +$1.42M | 0.02% | 640 |
|
|
2019
Q4 | $1.66M | Sell |
17,949
-180,855
| -91% | -$15.9M | 0.01% | 797 |
|
|
2019
Q3 | $18M | Buy |
198,804
+10,668
| +6% | +$1.22M | 0.12% | 194 |
|
|
2019
Q2 | $22.2M | Buy |
188,136
+165,070
| +716% | +$16.6M | 0.15% | 155 |
|
|
2019
Q1 | $2M | Buy |
23,066
+2,598
| +13% | +$221K | 0.01% | 647 |
|
|
2018
Q4 | $1.29M | Hold |
20,468
| – | – | 0.01% | 714 |
|
|
2018
Q3 | $1.61M | Buy |
20,468
+10,800
| +112% | +$704K | 0.01% | 706 |
|
|
2018
Q2 | $578K | Buy |
+9,668
| New | +$520K | 0.01% | 599 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Mirae Asset Global Investments's EXAS Position: Q1 2026 in Review
Mirae Asset Global Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 430 shares — an estimated $43.7K sold.
Mirae Asset Global Investments first reported a position in EXAS in Q2 2018 and held it in 27 quarters. The position peaked at $22.2M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Mirae Asset Global Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Mirae Asset Global Investments sold 430 Exact Sciences shares in Q1 2026, an estimated $43.7K.
- Mirae Asset Global Investments first reported a position in Exact Sciences in Q2 2018 and held it in 27 quarters.
- Mirae Asset Global Investments's Exact Sciences position peaked at $22.2M in Q2 2019.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.